Subarachnoid Hemorrhage, Aneurysmal Clinical Trial
Official title:
Trial of Prophylactic Decompressive Craniectomy for Poor-grade Aneurysmal Subarachnoid Hemorrhage
Decompressive craniectomy has been reported for the treatment of patients with aneurysmal subarachnoid hemorrhage (aSAH). But no prospective randomised controlled trials have yet been undertaken to confirm its effect.The purpose of the study is to determine whether decompressive craniectomy combine aneurysm clipping surgery or endovascular coiling will improve clinical outcomes of poor-grade aSAH patients.
Aneurysmal subarachnoid hemorrhage (aSAH) is a worldwide health burden with high fatality and permanent disability rates. Decompressive craniectomy, which is beneficial in patients with malignant middle cerebral artery infarction, may indirectly relieve the mass effect, decrease perihematomal tissue pressure, improve blood flow, reduce secondary brain damage and improve outcome without further damage to the brain due to surgery. Early therapy with either surgical clipping or neuroradiologic intervention with endovascular coiling is the primary treatment for aSAH. But whether decompressive craniectomy should be employed during the clipping surgery or immediately after coil embolization still have considerable controversy. 80 patients will be recruited to the trial over 12 months. Follow-up will take 6 months with analysis and reporting taking 6 months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06032533 -
Remote Ischemic Conditioning in Aneurysmal SAH
|
N/A | |
| Completed |
NCT05131295 -
Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.
|
Phase 3 | |
| Recruiting |
NCT04583163 -
Variability in Transcranial Doppler Technique in Neuro-Critical Care Patients
|
||
| Recruiting |
NCT06006975 -
Early Warning of Delayed Cerebral Ischemia
|
||
| Terminated |
NCT02893826 -
Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH
|
Phase 1 | |
| Unknown status |
NCT01567449 -
Risk Factors for Aneurysm Rebleeding
|
N/A | |
| Recruiting |
NCT05095857 -
The Anesthetic Ketamine as Treatment for Patients With Severe Acute Brain Injury
|
Phase 4 | |
| Not yet recruiting |
NCT04512859 -
Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage
|
N/A | |
| Recruiting |
NCT05103566 -
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
|
N/A | |
| Not yet recruiting |
NCT04696523 -
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
|
Phase 2 | |
| Completed |
NCT04415736 -
Artificial Intelligence in Subarachnoid Hemorrhage
|
||
| Recruiting |
NCT05925478 -
Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage
|
Early Phase 1 | |
| Recruiting |
NCT04649398 -
Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial Administration
|
||
| Recruiting |
NCT04945603 -
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
|
||
| Active, not recruiting |
NCT06239142 -
Understanding Mental Fatigue After Subarachnoid Hemorrhage
|
||
| Completed |
NCT03318783 -
Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
|
Phase 1/Phase 2 | |
| Terminated |
NCT05686265 -
Cerebral Nitrosative/Oxidative Stress in Aneurysmal Subarachnoid Haemorrhage
|
||
| Not yet recruiting |
NCT06359782 -
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
|
Phase 2 | |
| Not yet recruiting |
NCT06057155 -
Intracranial Pressure and Optic Nerve Sheath Diameter With CLOSED Bundle
|
||
| Completed |
NCT03115905 -
A Registry Study for Emergency Medical Service of Aneurysmal Subarachnoid Hemorrhage in China
|